Flagship Biosciences, Inc. — Form D

Flagship Biosciences, Inc. of BROOMFIELD, CO, a company, filed a Form D exempt-offering notice with the SEC on 2018-07-09. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Gary Dean ClarkDirectorWestminster, CO
Nancy Dean GillettDirectorWestminster, CO
G. David YoungDirectorWestminster, CO
Joe Dean KrugerExecutive OfficerWestminster, CO
Holger Dean LangeExecutive OfficerWestminster, CO
L. Dean NortheyExecutive OfficerWestminster, CO
G. David YoungExecutive OfficerWestminster, CO
Trevor JohnsonPromoterBroomfield, CO
G. David YoungPromoterWestminster, CO
William SniderDirectorBethesda, MD
Paul KirchgraberDirectorBroomfield, CO
Trevor JohnsonDirectorBroomfield, CO
Trevor JohnsonExecutive OfficerBroomfield, CO
Tom TuriDirectorBroomfield, CO
Tom TuriExecutive OfficerBroomfield, CO
Herb HooperDirectorBroomfield, CO
Bill H SniderDirectorBroomfield, CO
Fisher AaronDirectorBroomfield, CO
Herb H HooperDirectorBroomfield, CO
Tom H TuriDirectorBroomfield, CO
Dean David NortheyExecutive OfficerWestminster, CO
Nancy A GillettDirectorWestminster, CO
Gary M ClarkDirectorWestminster, CO
Gregory K TuckerDirectorWestminster, CO

Other filings by this issuer (5)

FiledFormOfferingSold
2024-04-18D$6.4M$5.0M
2024-02-21D/A$5.0M$3.0M
2023-12-14D$1.5M$1.5M
2022-09-09D$15.3M$15.3M
2018-03-16D$1.0M$1.0M

More